Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial

DiscussionIf EPO is found to reduce the cognitive side effects of ECT, this could have important implications for future treatment strategies for depression and for the scientific understanding of the neurobiological etiology of cognitive dysfunction in patients treated with ECT.Trial registrationClinicalTrials.gov,NCT03339596. Registered on 10 November 2017.
Source: Trials - Category: Research Source Type: clinical trials